The immune system is built to recognize threats and resolve them. When resolution fails and low-grade inflammation persists for months or years, the consequences accumulate across tissue, the nervous system, and the regulatory pathways that govern them. In autoimmunity, the immune system loses tolerance for the body’s own tissue, and antibodies form against healthy structures. Persistent pain syndromes often involve central sensitization, a neurological state in which ordinary signals begin to register as painful and the threshold for triggering pain drops over time.
Multiple drivers usually coexist. Gut barrier integrity is a frequent factor: the intestinal lining, when compromised, allows microbial fragments and undigested food proteins into circulation, where they train the immune system toward chronic vigilance and contribute to molecular mimicry, a primary trigger for autoimmune antibody formation. The microbiome itself shapes immune tone; certain compositions push the system toward chronic Th17 activation, the immunological branch most implicated in autoimmune disease. The autonomic nervous system factors in heavily. A sympathetic-dominant state amplifies inflammatory signaling. Reduced vagal activity weakens the cholinergic anti-inflammatory reflex, the body’s built-in brake on systemic inflammation. Mitochondrial dysfunction often accompanies these states. The cellular machinery responsible for resolving inflammation runs short on energy, and inflammation accumulates.
Symptoms persist as long as the upstream drivers persist. NSAIDs and immunosuppressants address symptom layers and inflammatory cascades, providing real and often necessary relief. Durable change happens upstream: identifying what has shifted in the gut, the autonomic nervous system, mitochondrial function, and immune regulation, then restoring each.